PL4001298T3 - Kompozycja o poliwalentnej immunogenności na wirusa brodawczaka ludzkiego - Google Patents

Kompozycja o poliwalentnej immunogenności na wirusa brodawczaka ludzkiego

Info

Publication number
PL4001298T3
PL4001298T3 PL20843624.6T PL20843624T PL4001298T3 PL 4001298 T3 PL4001298 T3 PL 4001298T3 PL 20843624 T PL20843624 T PL 20843624T PL 4001298 T3 PL4001298 T3 PL 4001298T3
Authority
PL
Poland
Prior art keywords
polyvalent
human papillomavirus
immunogenicity composition
immunogenicity
composition
Prior art date
Application number
PL20843624.6T
Other languages
English (en)
Inventor
Liangzhi Xie
Chunxia LUO
Wei Zhang
Xiaoyan SUO
Lin Pang
Ping Hu
Original Assignee
Sinocelltech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinocelltech Ltd filed Critical Sinocelltech Ltd
Publication of PL4001298T3 publication Critical patent/PL4001298T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20843624.6T 2019-07-19 2020-07-17 Kompozycja o poliwalentnej immunogenności na wirusa brodawczaka ludzkiego PL4001298T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910657255 2019-07-19
PCT/CN2020/102601 WO2021013071A1 (zh) 2019-07-19 2020-07-17 人乳头瘤病毒多价免疫原性组合物

Publications (1)

Publication Number Publication Date
PL4001298T3 true PL4001298T3 (pl) 2025-06-16

Family

ID=74193232

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20843624.6T PL4001298T3 (pl) 2019-07-19 2020-07-17 Kompozycja o poliwalentnej immunogenności na wirusa brodawczaka ludzkiego

Country Status (15)

Country Link
US (1) US12440549B2 (pl)
EP (1) EP4001298B1 (pl)
JP (2) JP7791078B2 (pl)
KR (1) KR102878566B1 (pl)
CN (1) CN114127092B (pl)
AU (1) AU2020317321B2 (pl)
BR (1) BR112022001070A2 (pl)
CA (1) CA3147849A1 (pl)
ES (1) ES3015251T3 (pl)
HU (1) HUE071793T2 (pl)
MX (1) MX2022000777A (pl)
MY (1) MY207280A (pl)
PL (1) PL4001298T3 (pl)
WO (1) WO2021013071A1 (pl)
ZA (1) ZA202201571B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240075124A1 (en) * 2021-01-14 2024-03-07 Sinocelltech Ltd Stable formulation of human papillomavirus virus-like particle vaccine
CN115960178B (zh) * 2022-12-28 2023-09-08 北京康乐卫士生物技术股份有限公司 人乳头瘤病毒hpv59 l1蛋白的表达和类病毒样颗粒及其制备方法
KR20250152098A (ko) * 2023-03-07 2025-10-22 베이징 헬스 가드 바이오테크놀러지 인크. 인유두종 바이러스 백신 및 이의 응용

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000092I1 (de) * 1994-10-07 2008-03-27 Univ Loyola Chicago Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung
US5821087A (en) * 1995-03-30 1998-10-13 Merck & Co., Inc. Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
GB0206359D0 (en) 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
DK2154149T3 (da) 2007-05-29 2019-10-14 Univ Xiamen En trunkeret l1-protein af human papillomavirus 6
CN101518647A (zh) * 2008-02-29 2009-09-02 江阴艾托金生物技术有限公司 人乳头瘤病毒预防性疫苗、构建方法及应用
WO2012000454A1 (zh) * 2010-07-02 2012-01-05 厦门大学 截短的人乳头瘤病毒52型l1蛋白
US9771397B2 (en) 2011-12-01 2017-09-26 University Of Cape Town HPV chimaeric particle
CN102747047B (zh) * 2012-02-28 2016-03-23 厦门大学 人乳头瘤病毒型别杂合病毒样颗粒及其制备方法
CN104120088B (zh) * 2013-04-26 2019-09-24 北京安百胜生物科技有限公司 用汉逊酵母表达系统产生hpv58 l1蛋白的方法
WO2015196112A1 (en) * 2014-06-19 2015-12-23 The Regents Of The University Of Colorado, A Body Corporate Human papilloma virus constructs

Also Published As

Publication number Publication date
KR102878566B1 (ko) 2025-10-30
CN114127092A (zh) 2022-03-01
MX2022000777A (es) 2022-02-14
WO2021013071A1 (zh) 2021-01-28
EP4001298B1 (en) 2025-03-05
BR112022001070A2 (pt) 2022-04-19
EP4001298A4 (en) 2023-03-15
EP4001298A1 (en) 2022-05-25
MY207280A (en) 2025-02-13
AU2020317321A1 (en) 2022-03-10
JP2026009143A (ja) 2026-01-19
KR20220074855A (ko) 2022-06-03
JP7791078B2 (ja) 2025-12-23
JP2022540950A (ja) 2022-09-20
CA3147849A1 (en) 2021-01-28
ES3015251T3 (en) 2025-04-30
HUE071793T2 (hu) 2025-09-28
EP4001298C0 (en) 2025-03-05
US12440549B2 (en) 2025-10-14
US20220370590A1 (en) 2022-11-24
AU2020317321B2 (en) 2023-07-27
ZA202201571B (en) 2025-05-28
CN114127092B (zh) 2024-04-16

Similar Documents

Publication Publication Date Title
SG11202010821TA (en) Vaccine composition
EP3108868A4 (en) Dental restorative composition
GB201711635D0 (en) Immunogenic composition
IL280332A (en) A preparation containing a flu vaccine
PT3646847T (pt) Composição de cura dentária do tipo duas pastas
ZA202001561B (en) Human cytomegalovirus immunogenic composition
EP3854417A4 (en) COMPOSITION FOR VACCINE AGAINST SWINE FEVER AND METHOD FOR PREPARATION
GB201802339D0 (en) Immunogenic composition
EP3302543A4 (en) Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
PL4001298T3 (pl) Kompozycja o poliwalentnej immunogenności na wirusa brodawczaka ludzkiego
EP3895682A4 (en) DENTAL COMPOSITION
EP4397316A4 (en) COMPOSITION TO IMPROVE IMMUNOGENICITY
SG11202009147UA (en) Vaccine compositions
EP3701930A4 (en) DENTAL COMPOSITION
IL291559A (en) Immunogenic preparations
GB201711637D0 (en) Immunogenic composition
SG11202105823TA (en) Compositions and methods for detecting human papillomavirus
SG11202103389WA (en) Immunogenic compositions
GB201910794D0 (en) Vaccine
EP3741388A4 (en) IMMUNOGENIC COMPOSITION
EP3706707A4 (en) MEDICAL FILLER COMPOSITION
GB202013262D0 (en) Vaccine Composition
GB201911636D0 (en) Vaccine
GB201803692D0 (en) Immunogenic composition
EP3677276A4 (en) VACCINE COMPOSITION